Newsroom

New Investment Round Opened

June 1, 2021

Canine Biologics has begun a new round of fundraising via the Crowdfunding platform, Wefunder. Capital raised during this round will provide for ongoing operations, expanded marketing efforts, new product development, and foreign market entry.

Jeff Sutherland, Founder and CEO of Canine Biologics noted, “The additional capital provided in this round will allow us to serve even more veterinarians, pet parents and most importantly be available to more dogs battling cancer. Though we are now being recommended by many oncologists, internists and GPs, we want to go well beyond our current 24 state footprint. And our roadmap calls for the development of some truly innovative products such as a liquid diet for dogs requiring tube feeding, treats that complement our Integrated Nutrition System and additional supplements that support dogs with different types of cancer.”

Mr. Sutherland continues, “Investors may participate in this round for as little as $100. That is one of the advantages of using a Crowdfunding platform. Though a passion for dogs will motivate many investors in this round, others will see that Canine Biologics could provide a significant return. We have joined a industry that in the US has grown at an average of 5% every year since 1984 and will be worth $110 billion in 2021.”

To see details of this round, go to https://wefunder.com/caninebiologics

Canine Biologics Forms in Denver With A Mission to Provide Specialized System of Nutrition for Dogs with Cancer

Building on his life long love of dogs and his history of developing restaurant quality food for dogs, Jeff Sutherland forms Canine Biologics. Jeff's vision for Canine Biologics is to provide a scientifically based system of food and supplements to support dogs fighting cancer.